Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
303 questions in 64 reviews · Hepato-Biliary
current versionsNo studies 303 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Radioembolisation plus sorafenib vs sorafenib monotherapy Tumour response assessments · people with hepatocellular carcinoma Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma (2020) · Cochrane | no estimate extracted | NR | No studies |
Sclerotherapy vs no intervention Health‐related quality of life · primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in… (2020) · Cochrane | no estimate extracted | NR | No studies |
N‐acetylcysteine vs placebo Resolution of encephalopathy and coagulopathy ‐ not reported · children with non‐paracetamol (acetaminophen)‐related acute liver failure N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure (2020) · Cochrane | no estimate extracted | NR | No studies |
N‐acetylcysteine vs placebo Quality of life ‐ not reported · children with non‐paracetamol (acetaminophen)‐related acute liver failure N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure (2020) · Cochrane | no estimate extracted | NR | No studies |
N‐acetylcysteine vs placebo Serious adverse events · adult patients with non‐paracetamol (acetaminophen)‐related acute liver failure N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure (2020) · Cochrane | no estimate extracted | NR | No studies |
N‐acetylcysteine vs placebo Resolution of encephalopathy and coagulopathy · adult patients with non‐paracetamol (acetaminophen)‐related acute liver failure N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure (2020) · Cochrane | no estimate extracted | NR | No studies |
N‐acetylcysteine vs placebo Quality of life · adult patients with non‐paracetamol (acetaminophen)‐related acute liver failure N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Interventions · people with liver cirrhosis and ascites Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Serious adverse events (number of people) · people with liver cirrhosis and ascites Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Paracentesis plus fluid replacement · people with liver cirrhosis and ascites Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · people with liver cirrhosis and ascites Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Symptomatic resolution of ascites at maximal · people with liver cirrhosis and ascites Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Interventions · people with liver cirrhosis Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR No active intervention · people with liver cirrhosis Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Interventions · adults undergoing liver transplantation Induction immunosuppression in adults undergoing liver transplantation: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · adults undergoing liver transplantation Induction immunosuppression in adults undergoing liver transplantation: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Glucocorticosteroids · adults undergoing liver transplantation Induction immunosuppression in adults undergoing liver transplantation: a network meta‐analysis (2020) · Cochrane | no estimate extracted | NR | No studies |
Other plasma expanders vs albumin Refractory ascites · cirrhotic participants with large ascites treated by paracentesis Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis (2019) · Cochrane | no estimate extracted | NR | No studies |
Plasma expanders vs no plasma expanders Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis (2019) · Cochrane | no estimate extracted | NR | No studies |
Plasma expanders vs no plasma expanders Refractory ascites · cirrhotic participants with large ascites treated by paracentesis Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis (2019) · Cochrane | no estimate extracted | NR | No studies |
Other plasma expanders vs albumin Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cancer mortality · people with liver metastases Cryotherapy for liver metastases (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · people with liver metastases Cryotherapy for liver metastases (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Time to progression of liver metastases · people with liver metastases Cryotherapy for liver metastases (2019) · Cochrane | no estimate extracted | NR | No studies |
Phamacotherapies that specifically target ammonia vs placebo or non‐absorbable disaccharides Hepatic encephalopathy · adults with cirrhosis and hepatic encephalopathy Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic… (2019) · Cochrane | no estimate extracted | NR | No studies |
Phamacotherapies that specifically target ammonia vs placebo or non‐absorbable disaccharides Health‐related quality of life · adults with cirrhosis and hepatic encephalopathy Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic… (2019) · Cochrane | no estimate extracted | NR | No studies |
Band ligation vs no intervention Outcomes* · adults with oesophageal varices Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults… (2019) · Cochrane | no estimate extracted | NR | No studies |
Band ligation vs no intervention Non‐serious adverse events · adults with oesophageal varices Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults… (2019) · Cochrane | no estimate extracted | NR | No studies |
Band ligation vs no intervention Health‐related quality of life · adults with oesophageal varices Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults… (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs no intervention or placebo Health‐related quality of life · chronic hepatitis B Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs no intervention or placebo Hepatitis B‐related mortality · chronic hepatitis B Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs no intervention or placebo Hepatitis B‐related morbidity · chronic hepatitis B Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Xiao Chai Hu Tang formula vs no intervention All‐cause mortality · chronic hepatitis B Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Xiao Chai Hu Tang formula vs no intervention Proportion of participants with ≥ 1 serious adverse events · chronic hepatitis B Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Xiao Chai Hu Tang formula vs no intervention Health‐related quality of life · chronic hepatitis B Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Xiao Chai Hu Tang formula vs no intervention Hepatitis B‐related mortality · chronic hepatitis B Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Xiao Chai Hu Tang formula vs no intervention Hepatitis B‐related morbidity · chronic hepatitis B Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Interventions · people with hepatorenal syndrome with decompensated liver cirrhosis Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Albumin plus terlipressin · people with hepatorenal syndrome with decompensated liver cirrhosis Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs other drugs or herbs All‐cause mortality · chronic hepatitis B Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs other drugs or herbs Proportion of participants with ≥ 1 serious adverse events · chronic hepatitis B Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs other drugs or herbs Health‐related quality of life · chronic hepatitis B Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs other drugs or herbs Hepatitis B‐related mortality · chronic hepatitis B Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Radix Sophorae flavescentis vs other drugs or herbs Hepatitis B‐related morbidity · chronic hepatitis B Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention All‐cause mortality · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention Proportion of participants with 1 or more serious adverse events · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention Health‐related quality of life · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention Hepatitis B‐related mortality · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention Hepatitis B‐related morbidity · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs no intervention Exploratory outcomes: Proportion of participants with detectable HBV DNA (at maximum · chronic hepatitis B Acupuncture for chronic hepatitis B (2019) · Cochrane | no estimate extracted | NR | No studies |